thyroid cancer

• Ear_Thyroid_DOC(Weekly)+Rad

head and neck cancer

• Ear_Head and Neck FC+Pembro_q3W
• Ear_Head and neck CBDCA+PTX(2W1R)+Cet(Weekly)2-
• Ear_Head and neck CBDCA+PTX(2W1R)+Cet(Weekly)1st
• Ear_Head and Neck CBDCA+5FU[FC]_q3W
• Ear_Head and Neck FC(q3W)+Cet(Weekly)(Outpatient)_2-
• Ear_Head and Neck FC(q3W)+Cet(Weekly)(Outpatient)_1st
• Ear_Head and Neck Pembrolizumab_q6W
• Ear_Head and Neck_CBDCA(Weekly)+Rad
• Ear_Head and neck_Cetuximab(weekly 2~)+Rad
• Ear_Head and neck_Cetuximab(weekly 1st)+Rad
• Ear_Head and Neck_CDDP(Weekly)+Rad
• Ear_Head and Neck_DOC+CBDCA_q3W
• Ear_Head and Neck_DOC_q3W
• Ear_Head and neck_Nivolumab(240mg_body)_q2W
• Ear_Head and Neck_DOC+CDGP_q4W
• Ear_Head and neck_Cetuximab(weekly)_2~
• Ear_Head and Neck_PTX6W1R
• Ear_Head and Neck_PTX+Cet_Weekly_1st
• Ear, head and neck, Nivolumab (3 mg kg) q2W
• Ear_Head and Neck_PTX+Cet_Weekly_2~